Company Filing History:
1 out of 1,777 
1 out of 1,384 Years Active: 2007
Title: The Innovations of Frederik Christian Grønvald
Introduction
Frederik Christian Grønvald, an inventive mind hailing from Vedbæk, Denmark, has made significant contributions to the field of biotechnology. With a focus on meiosis, his research has the potential to impact reproductive health substantially. His pioneering work in developing novel compounds showcases the importance of innovation in scientific progress.
Latest Patents
Grønvald holds one patent related to "Meiosis Regulating Compounds." This patent involves certain novel sterol derivatives that can be used to regulate meiosis in oocytes and male germ cells. His findings hold promise for advancing understanding and treatment options in fields related to reproduction and fertility.
Career Highlights
Throughout his career, Frederik has been associated with prominent companies in the pharmaceutical and biotechnology sectors. He has worked with Novo Nordisk A/S and Schering Aktiengesellschaft, where he honed his skills and expanded his expertise in drug development and innovative research.
Collaborations
In his professional journey, Grønvald has collaborated with notable colleagues, including Peter Faarup and Thorsten Blume. These partnerships have likely facilitated the exchange of ideas and fostered environments conducive to groundbreaking research.
Conclusion
Frederik Christian Grønvald's work exemplifies the spirit of innovation and the importance of invention in biotechnology. His contributions, particularly in meiosis regulation, pave the way for future advancements in reproductive health and medicine. As the field continues to evolve, his discoveries will undoubtedly inspire upcoming generations of scientists and researchers.